Clinical Trials Logo

Clinical Trial Summary

This investigation is a Post Marketing Follow-Up Study for Mepilex XT conducted as part of Mölnlycke Health Care's quality system. The primary objective is to evaluate the performance of the dressing when used as intended on exuding Venous Leg Ulcers (VLUs) in the inflammatory and granulating stages of the wound healing process.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02167815
Study type Interventional
Source Molnlycke Health Care AB
Contact
Status Completed
Phase N/A
Start date May 2014
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT01970657 - Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 N/A